GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
Start Date
3/2/2026
Completion Date
3/1/2036
Summary
A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.
Detailed Description
Minimum of 125 total subjects with a TBE Device implantation procedure initiated in up to 50 Sites in the United States. Subjects will have follow-up at 1 Month, 6 Month, 1 Year, and annually thereafter for a minimum of 5-years and up to a maximum of 10 years.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
GORE® TAG® Thoracic Branch Endoprosthesis
Conditions
Locations
Keck Medical Center of USC
Los Angeles, California 90033
United States
Hartford Hospital
Hartford, Connecticut 06102
United States
University of Florida Health Heart & Vascular
Gainesville, Florida 32608
United States
Lakeland Regional Medical Center
Lakeland, Florida 33805
United States
University of South Florida
Tampa, Florida 33606
United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina 27599
United States
Duke University Medical Center
Durham, North Carolina 27710
United States
The Methodist Hospital-Houston
Houston, Texas 77030
United States
Baylor Scott & White Research Institute
Plano, Texas 75093
United States
Intermountain Medical Center
Murray, Utah 84107
United States
University of Washington Medical Center
Seattle, Washington 98195
United States
University of Wisconsin - Madison
Madison, Wisconsin 53792
United States
Medical College of Wisconsin
Milwaukee, Wisconsin 53226
United States